Expression and Role of Vascular Endothelial Growth Factor in Liver Regeneration After Partial Hepatectomy in Rats

Vascular endothelial growth factor (VEGF) plays a major role in angiogenesis, which is essential for both healing of injured tissue and proliferation of carcinoma cells. In this study we elucidated the expression and role of VEGF in rat liver regeneration after partial hepatectomy. VEGF expression was mainly detected in periportal hepatocytes and reached a maximal level 48–72 hr after partial hepatectomy by both immunohistochemistry and in situ hybridization. Similarly, immunohistochemistry for Ki-67 showed that the proliferative activity of sinusoidal endothelial cells was highest in the periportal area and reached a maximal level 72 hr after partial hepatectomy. Moreover, neutralization of VEGF significantly inhibited proliferative activity of hepatocytes (p < 0.0001), as well as sinusoidal endothelial cells (p < 0.001), at 48 and 96 hr after partial hepatectomy. Conversely, injection of VEGF significantly promoted proliferative activity of hepatocytes (p < 0.0001) as well as sinusoidal endothelial cells (p < 0.0005) at 48 hr after partial hepatectomy. These results suggest that VEGF promotes proliferation of hepatocytes through reconstruction of liver sinusoids by proliferation of sinusoidal endothelial cells. Furthermore, these data point to a new therapeutic strategy, the use of VEGF and other hepatocyte growth factors in fulminant or severe acute hepatitis.

[1]  Y. Baruch,et al.  Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. , 1999, Journal of hepatology.

[2]  T. Akaike,et al.  Expression of vascular endothelial growth factor promotes colonization, vascularization, and growth of transplanted hepatic tissues in the mouse , 1999, Hepatology.

[3]  M. Kay,et al.  Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral‐mediated gene transfer in mice , 1998, Hepatology.

[4]  A. Palotie,et al.  Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation , 1998, Thrombosis and Haemostasis.

[5]  E. Ingham,et al.  Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. , 1998, British Journal of Cancer.

[6]  D. Rockey,et al.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. , 1998, Gastroenterology.

[7]  J. Gerdes,et al.  Ki‐67 expression during rat liver regeneration after partial hepatectomy , 1997, Hepatology.

[8]  A. Terano,et al.  Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing. , 1997, Biochemical and biophysical research communications.

[9]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[10]  海堀 昌樹.  Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocyte growth factor , 1997 .

[11]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.

[12]  M. Shibuya,et al.  Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. , 1996, Biochemical and biophysical research communications.

[13]  David C. Lee,et al.  Liver regeneration and hepatocarcinogenesis in transforming growth factor‐α‐targeted mice , 1996 .

[14]  木曽 真一.  Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy , 1996 .

[15]  W. Russell,et al.  Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. , 1996, Molecular carcinogenesis.

[16]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[17]  S. Kondo,et al.  Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121). , 1995, Hybridoma.

[18]  H. Dvorak,et al.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. , 1995, The Journal of investigative dermatology.

[19]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[20]  K. Alitalo,et al.  Endothelial receptor tyrosine kinases involved in angiogenesis , 1995, The Journal of cell biology.

[21]  H. Kawasaki,et al.  Serum hepatocyte growth factor levels in liver diseases: Clinical implications , 1995, Hepatology.

[22]  M. Shibuya.  Role of VEGF-flt receptor system in normal and tumor angiogenesis. , 1995, Advances in cancer research.

[23]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[24]  M. Shibuya,et al.  A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). , 1994, Oncogene.

[25]  B Swolin,et al.  Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.

[26]  T. Nakamura,et al.  Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expression , 1994, Hepatology.

[27]  Y. Matsuzawa,et al.  Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. , 1994, Biochemical and biophysical research communications.

[28]  N. Fausto,et al.  Transforming growth factor‐α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor‐α and hepatocyte growth factor , 1993 .

[29]  Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo , 1992, Hepatology.

[30]  S. Hayashi,et al.  Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. , 1992, Gastroenterology.

[31]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[32]  S. Hirono,et al.  Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor , 1992, The Lancet.

[33]  M. Monden,et al.  Hepatocyte growth factor concentrations after liver resection , 1992, The Lancet.

[34]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[35]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[36]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[37]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[38]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[39]  R. Cotran,et al.  MONONUCLEAR PHAGOCYTES (KUPFFER CELLS) AND ENDOTHELIAL CELLS , 1972, The Journal of cell biology.

[40]  H. W. Chalkley,et al.  Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .

[41]  G. Higgins,et al.  Experimental pathology of the liver , 1931 .